Author

Siras Hakobyan

Institute of Molecular BiologyORCID 0000-0002-6875-2482Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Siras Hakobyan1 paper · Yerevan Institute of Molecular Biology;

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Ali El‐Ayoubi· 1 shared Arsen ArakelyaniD· 1 shared Irene González-MenéndeziD· 1 shared Leticia Quintanilla de Fend· 1 shared Luisa Merk· 1 shared Lusine DanielyaniD· 1 shared Matthias Georg SchwabiD· 1 shared Moritz Klawitter· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Ali El‐Ayoubi

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Development of an optimized, non-stem cell line for intranasal delivery of therapeutic cargo to the central nervous system

Ali El‐Ayoubi, Arsen Arakelyan, Moritz Klawitter, Luisa Merk, Siras Hakobyan, Irene González-Menéndez, Leticia Quintanilla de Fend, Per Sonne Holm, Wolfgang Mikulits, Matthias Georg Schwab, Lusine Danielyan, Ulrike Naumann

The paper develops a non-tumorigenic cell line, LX-2, for intranasal delivery of oncolytic viruses to the brain, showing improved resistance to viral replication and safety in mice.

Molecular Oncology · Dec 20, 2023Peer-reviewedMolecular Biology